Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1634 1682
This examiner grants 53% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17813193 | ncRNA AND USES THEREOF | Final Rejection | THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 17570315 | METHODS FOR DIAGNOSIS OF BACTERIAL AND VIRAL INFECTIONS | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 17596821 | Diagnostics and Treatments Based Upon Molecular Characterization of Colorectal Cancer | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 18025365 | METHODS OF DETECTING AN INACTIVATING MUTATION OF PBRM1 IN MENINGIOMA | Final Rejection | Foundation Medicine, Inc. |
| 17921936 | COMPOSITIONS AND METHODS FOR SEQUENCING USING POLYMER BRIDGES | Non-Final OA | Illumina, Inc. |
| 18546515 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID DETECTION BY LATERAL FLOW ASSAYS | Non-Final OA | King Abdullah University of Science and Technology |
| 16562861 | DIAGNOSTIC AND PROGNOSTIC LIQUID BIOPSY BIOMARKERS FOR ASTHMA | Non-Final OA | University of Sharjah |
| 18229323 | Methods for Treating Eosinophilic Esophagitis | Final Rejection | Children's Hospital Medical Center |
| 16760522 | CANCER DETECTION, CLASSIFICATION, PROGNOSTICATION, THERAPY PREDICTION AND THERAPY MONITORING USING METHYLOME ANALYSIS | Final Rejection | SINAI HEALTH SYSTEM |
| 17290061 | Bispecific CD123 x CD3 Diabodies for the Treatment of Hematologic Malignancies | Final Rejection | Nottingham Trent University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy